Scenarios that move AURA

Aura Biosciences, Inc. - Common Stock

Scenarios that move AURA: 1 analysis, 0 positive, 1 negative.

  1. · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▼ · impact -18 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing